Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US HHS Pulled Recommendation To Make Kratom A Controlled Substance, But Kept Mum On Change
Agency Recently Disclosed 2018 Letter To DEA Rescinding Findings To Schedule Kratom
Jan 29 2021
•
By
Malcolm Spicer
More from Regulation
More from Policy & Regulation